Show simple item record

dc.contributor.authorShubitz, L.F.
dc.contributor.authorPowell, D.A.
dc.contributor.authorDial, S.M.
dc.contributor.authorButkiewicz, C.D.
dc.contributor.authorTrinh, H.T.
dc.contributor.authorHsu, A.P.
dc.contributor.authorBuntzman, A.
dc.contributor.authorFrelinger, J.A.
dc.contributor.authorGalgiani, J.N.
dc.date.accessioned2022-12-15T22:41:44Z
dc.date.available2022-12-15T22:41:44Z
dc.date.issued2022
dc.identifier.citationShubitz, L. F., Powell, D. A., Dial, S. M., Butkiewicz, C. D., Trinh, H. T., Hsu, A. P., Buntzman, A., Frelinger, J. A., & Galgiani, J. N. (2022). Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease. Journal of Fungi, 8(10).
dc.identifier.issn2309-608X
dc.identifier.doi10.3390/jof8100991
dc.identifier.urihttp://hdl.handle.net/10150/667244
dc.description.abstractThe majority of human coccidioidomycosis infections are asymptomatic or self-limited but may have sequestered spherules in highly structured granulomas. Under immunosuppression, reactivation of fungal growth can result in severe disease. B6D2F1 mice asymptomatically infected with C. posadasii strain 1038 were immunosuppressed with dexamethasone (DXM) in drinking water. Treated mice died 16–25 days later, while untreated mice survived (p < 0.001). Flow cytometry of lung granulomas on days 5, 10, 15, and 20 of DXM treatment showed immune cell populations decreased 0.5–1 log compared with untreated mice though neutrophils and CD19+IgD−IgM− cells rebounded by day 20. Histopathology demonstrated loss of granuloma structure by day 5 and increasing spherules through day 20. On day 20, T-cells were nearly absent and disorganized pyogranulomatous lesions included sheets of plasma cells and innumerable spherules. Mice given DXM for 14 days then stopped (DXM stop) survived 6 weeks (9/10). Lung fungal burdens were significantly lower (p = 0.0447) than mice that continued treatment (DXM cont) but higher than untreated mice. Histopathologically, DXM stop mice did not redevelop controlled granulomas by sacrifice, though T-cells were densely scattered throughout the lesions. This demonstrates a mouse model suitable for further study to understand the immunologic components responsible for maintenance control of coccidioidomycosis. © 2022 by the authors.
dc.language.isoen
dc.publisherMDPI
dc.rightsCopyright © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectCoccidioides
dc.subjectgranuloma
dc.subjectimmunosuppression
dc.subjectmice
dc.subjectreactivation
dc.titleReactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease
dc.typeArticle
dc.typetext
dc.contributor.departmentValley Fever Center for Excellence, University of Arizona
dc.contributor.departmentDepartment of Immunobiology, University of Arizona
dc.contributor.departmentCollege of Veterinary Medicine, University of Arizona
dc.contributor.departmentBIO5, University of Arizona
dc.contributor.departmentDepartment of Medicine, University of Arizona
dc.identifier.journalJournal of Fungi
dc.description.noteOpen access journal
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal published version
dc.source.journaltitleJournal of Fungi
refterms.dateFOA2022-12-15T22:41:44Z


Files in this item

Thumbnail
Name:
jof-08-00991.pdf
Size:
2.642Mb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

Copyright © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as Copyright © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).